𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth

✍ Scribed by Manoj Garg; Deepika Kanojia; Sushma Suri; Anil Suri


Book ID
102805870
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
696 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND:

The expression of the SPAG9 is associated with various human malignancies. Earlier work revealed a significant association of SPAG9 expression with the early spread of cervical cancer, making it an attractive therapeutic target. Here, the authors investigated the role of SPAG9 in carcinogenesis of squamous cell carcinoma (SCC) of the cervix. Furthermore, they sought to determine whether ablation of SPAG9 expression reduces the tumor growth of cervical SCC in vivo.

METHODS:

A plasmid‐based small interfering RNA approach was used to specifically knock down the expression of SPAG9 in SiHa cells derived from SCC of the cervix in vitro and in vivo. Reverse transcriptase polymerase chain reaction, immunofluorescence staining, flow cytometry, cellular growth, colony formation, migration, invasion, and wound healing assays were studied to characterize SPAG9 in vitro. Furthermore, a cervical cancer xenograft model in nude mice was established to investigate whether knockdown of SPAG9 reduces the tumor growth of cervical SCC in vivo.

RESULTS:

The results demonstrated that silencing the SPAG9 by small interfering RNA resulted in inhibition of cell growth, colony formation, migration, and invasion. The authors showed for the first time that the knockdown of SPAG9 expression by small interfering RNA significantly suppressed the tumor growth of cervical SCC in vivo.

CONCLUSIONS:

These results suggest that SPAG9 expression may play a pivotal role in tumor growth and could contribute to the early spread of cervical cancer. Small interfering RNA‐mediated down‐regulation of SPAG9 represents a promising therapeutic approach for the treatment of cervical cancer. Cancer 2009. Β© 2009 American Cancer Society.


πŸ“œ SIMILAR VOLUMES


Small interfering RNA-mediated CXCR1 or
✍ Seema Singh; Anguraj Sadanandam; Michelle L. Varney; Kalyan C. Nannuru; Rakesh K πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 429 KB

## Abstract CXCR1 and CXCR2 are receptors for CXCL‐8 and are differentially expressed on melanoma and endothelial cells. In this study, we determined the functional role of these receptors in melanoma progression. We stably knock‐down the expression of CXCR1 and/or CXCR2 in A375‐SM (SM; high metast